In a report released today, Travis Steed from Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report).

In a report released today, Matt Miksic from Barclays reiterated a Buy rating on Medtronic (MDT – Research Report), with a price target ...

The lawsuit, filed Tuesday in U.S. District Court in Delaware, is the latest in a series of patent challenges against ...

Dr. Shirin Towfigh claims the medical device giant “knowingly copied” her design for a hernia device treatment.

Robotic surgery, with its advantages over conventional open and laparoscopic surgeries—such as faster recovery times, reduced ...

SCSU’s MedTech programs give students more than a degree — they open doors to an exciting field that has the power to change ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

The pulse oximeter, a device that measures the degree to which red blood cells are saturated with oxygen, is one of healthcare's most fundamental tools.

NeurAxis (NASDAQ:NRXS – Get Free Report) and Medtronic (NYSE:MDT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...

The latest trading day saw Medtronic (MDT) settling at $87.72, representing a -0.45% change from its previous close.

Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor", "Ping An Health", or "the Company", Stock Code: ...